Deva Holding As Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DEVA HOLDING AS, and what generic and branded alternatives to DEVA HOLDING AS drugs are available?
DEVA HOLDING AS has ten approved drugs.
Drugs and US Patents for Deva Holding As
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Deva Holding As | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 210197-002 | Jan 12, 2024 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Deva Holding As | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 210197-001 | Jan 12, 2024 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Deva Holding As | TEMOZOLOMIDE | temozolomide | CAPSULE;ORAL | 207658-004 | Apr 26, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Deva Holding As | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 210197-004 | Jan 12, 2024 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Deva Holding As | AMOXICILLIN AND CLAVULANATE POTASSIUM | amoxicillin; clavulanate potassium | TABLET;ORAL | 209991-001 | Sep 15, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Deva Holding As | TEMOZOLOMIDE | temozolomide | CAPSULE;ORAL | 207658-005 | Apr 26, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Deva Holding As | TEMOZOLOMIDE | temozolomide | CAPSULE;ORAL | 207658-001 | Apr 26, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.